Plethora Solutions Holdings Plc Regulatory News (PLE)

24 May 2007 07:05

Plethora Solutions Holdings PLC24 May 2007 PLETHORA SOLUTIONS HOLDINGS PLC Plethora Solutions Holdings PLC ("Plethora", AIM: PLE), a company specialisingin the development and marketing of products for the treatment and management ofurological disorders, will be announcing its preliminary results for the yearended 31st December 2006 on Wednesday 30th May 2007. An analyst meeting will be held at 10am at the offices of Collins Stewart, 9thFloor, 88 Wood Street, London EC2V 7QR -Ends- For further information contact: Plethora Solutions Tel: 020 7269 8630Steven Powell City/Financial Enquiries Tel: 020 7379 5151MaitlandBrian Hudspith/Liz Morley Scientific/Trade Press Enquiries Tel: 020 7861 3838De Facto CommunicationsRichard Anderson About Plethora Solutions: Plethora is focused on the development and marketing of products for thetreatment of urological disorders. The Company has products in clinicaldevelopment for the treatment of overactive bladder, stress urinaryincontinence, interstitial cystitis, gynaecological pain and prematureejaculation. In January 2006, Plethora acquired Minneapolis (Mn) based TimmMedical Technologies Inc which markets the ErecAid(R) and Rigiscan(R) productsfor the treatment of erectile dysfunction (ED) to urology clinics through aUS-based specialty sales team. Most recently, the ErecAid has been found to beeffective for men that fail Medical Management and for men recovering fromprostatectomy The Company is headquartered in the UK and is listed on the LondonStock Exchange (AIM:PLE) Further information is available atwww.plethorasolutions.co.uk This information is provided by RNS The company news service from the London Stock Exchange